Related news from  |
Mon, 03 Nov 2025 15:43:00 +0000 |
Main Street Set to Release Q3 Earnings: What's in the Cards?
MAIN's Q3 results may show modest gains in earnings and revenues, aided by higher investment income and portfolio value growth.
|
Sat, 01 Nov 2025 00:23:22 +0000 |
Hercules Capital (HTGC): $71.1 Million One-Off Loss Pressures Margins Despite Attractive Valuation
Hercules Capital (HTGC) is trading at $17.92, which is below one estimate of fair value at $20.43. The company’s EPS currently results in a price-to-earnings ratio of 12.5x, undercutting both the peer average of 14.9x and the broader US capital markets industry at 25.6x. Over the past five years, Hercules Capital’s earnings have grown by 8.2% per year, with forward-looking expectations showing annual earnings growth of 9.5% and revenue growth of 7.8%, both lagging behind the US market as a...
|
Fri, 31 Oct 2025 12:56:00 +0000 |
HTGC Stock Up as Q3 Earnings Beat on Higher Total Investment Income
Hercules Capital's Q3 earnings top estimates as higher total investment income offsets rising expenses, lifting the stock in after-hours trading.
|
Fri, 31 Oct 2025 12:47:56 +0000 |
HTGC Q3 Deep Dive: Disciplined Lending Drives Portfolio Growth Amid Mixed Market Conditions
Specialty finance company Hercules Capital (NYSE:HTGC) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.3% year on year to $138.1 million. Its GAAP profit of $0.63 per share was 31.3% above analysts’ consensus estimates.
|
Fri, 31 Oct 2025 03:06:18 +0000 |
Hercules Capital Inc (HTGC) Q3 2025 Earnings Call Highlights: Record Originations and ...
Hercules Capital Inc (HTGC) reports strong financial performance with record originations and investment income, while navigating market frothiness and leverage concerns.
|
Thu, 30 Oct 2025 21:35:02 +0000 |
Hercules Capital (HTGC) Q3 Earnings Miss Estimates
Hercules Capital (HTGC) delivered earnings and revenue surprises of -2.08% and +4.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
|
Thu, 30 Oct 2025 20:28:27 +0000 |
Hercules Capital: Q3 Earnings Snapshot
SAN MATEO, Calif. AP) — Hercules Capital, Inc. HTGC) on Thursday reported profit of $119.7 million in its third quarter.
|
Thu, 30 Oct 2025 20:05:00 +0000 |
Hercules Capital Reports Third Quarter 2025 Financial Results
SAN MATEO, Calif., October 30, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2025. The earnings release can be accessed at Hercules’ Investor Relations website at ht
|
Wed, 29 Oct 2025 15:10:00 +0000 |
Ares Capital Q3 Earnings Meet Estimates, Total Investment Income Rises
ARCC's third-quarter earnings match estimates as higher investment income offset a rise in expenses and a dip in profit.
|
Wed, 29 Oct 2025 03:09:26 +0000 |
Hercules Capital (HTGC) Q3 Earnings: What To Expect
Specialty finance company Hercules Capital (NYSE:HTGC) will be reporting earnings this Thursday afternoon. Here’s what investors should know.
|
Tue, 28 Oct 2025 10:00:00 +0000 |
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2025
SAN MATEO, Calif., October 28, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third quarter 2025 total cash distribution of $0.47 per share. The following shows the key dates of the
|
Mon, 27 Oct 2025 22:06:09 +0000 |
Surpassing $25 Billion in Commitments Could Be a Game Changer for Hercules Capital (HTGC)
Hercules Capital recently celebrated surpassing US$25.0 billion in total cumulative debt commitments since its first origination in October 2004, highlighting its ongoing partnerships with more than 1,000 venture capital and private equity sponsors and financings for over 700 companies. This achievement underscores Hercules Capital’s significant role in providing growth capital to innovative, venture-backed companies in the technology and life sciences sectors. We'll explore how Hercules...
|
Mon, 27 Oct 2025 10:00:00 +0000 |
Hercules Capital Celebrates $25.0 Billion Milestone in Total Cumulative Debt Commitments
SAN MATEO, Calif., October 27, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is celebrating reaching the $25.0 billion milestone in total cumulative debt commitments since its first origination in October 2004.
|
Wed, 22 Oct 2025 16:14:00 +0000 |
Moody's Q3 Earnings Beat Estimates on Y/Y Revenue Growth
MCO posts strong Q3 results as revenues climb 10.7% y/y and earnings top estimates, prompting a raised full-year outlook.
|
Tue, 21 Oct 2025 22:00:04 +0000 |
Hercules Capital (HTGC) Stock Moves 1.37%: What You Should Know
Hercules Capital (HTGC) concluded the recent trading session at $17.73, signifying a +1.37% move from its prior day's close.
|
Mon, 20 Oct 2025 13:10:40 +0000 |
Viridian Therapeutics Signs $300 Million Royalty Financing Deal With DRI Healthcare
Viridian Therapeutics (VRDN) said Monday it signed a royalty financing deal with DRI Healthcare Acqu
|
Mon, 20 Oct 2025 11:30:00 +0000 |
Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million
WALTHAM, Mass., October 20, 2025--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potentially best-in-class medicines for serious and rare diseases, today announced it entered into a royalty financing agreement with DRI Healthcare Acquisitions LP (DRI) and accelerated its timelines for the submission of the veligrotug BLA and the topline clinical data readouts of its VRDN-003 REVEAL trials in patients with thyroid eye dis
|
Sun, 19 Oct 2025 23:04:44 +0000 |
Assessing Hercules Capital (HTGC) Valuation After Recent Share Price Volatility
Hercules Capital (HTGC) has recently caught the attention of market watchers after experiencing some noticeable stock movement. While there is not a specific news event driving recent changes, investors continue to weigh the company's fundamentals and performance. See our latest analysis for Hercules Capital. After climbing earlier in the year, Hercules Capital’s share price has recently pulled back, now sitting at $17.27 following a 30-day share price return of -10.15%. Despite some...
|
Thu, 16 Oct 2025 10:00:00 +0000 |
Hercules Capital Announces Date for Release of Third Quarter 2025 Financial Results and Conference Call
SAN MATEO, Calif., October 16, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2025 financial results conference call for Thursday, October 30, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules
|
Fri, 10 Oct 2025 04:50:20 +0000 |
3 Value Stocks with Open Questions
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
|